Syria’s pharmaceutical manufacturing sector is maintaining domestic supply stability while positioning itself for renewed export growth, according to Joseph Bahri, Managing Director of Bahripharm. Bahri said the country currently has around 90 licensed pharmaceutical manufacturers, with approximately 60 to 70 operating actively despite the challenges faced during the past decade. He …
Continue reading “Syrian pharmaceutical manufacturers target export growth amid cost advantages”
